{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:32:05Z","timestamp":1787610725641,"version":"build-2736575974"},"reference-count":27,"publisher":"Centers for Disease Control MMWR Office","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7132e4","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T11:10:35Z","timestamp":1659697835000},"page":"1023-1028","source":"Crossref","is-referenced-by-count":114,"title":["Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection \u2014 United States, August 2022"],"prefix":"10.15585","volume":"71","author":[{"given":"Jesse","family":"O\u2019Shea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Filardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna Bamrah","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Weiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R1","first-page":"537","article-title":"Multistate outbreak of monkeypox\u2014Illinois, Indiana, and Wisconsin, 2003.","volume":"52","author":"CDC","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R2","unstructured":"CDC. Monkeypox: monkeypox outbreak global map. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. Accessed August 4, 2022.https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/world-map.html"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2807\/1560-7917.es.2022.27.22.2200424","article-title":"Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022","volume":"27(22)","author":"Duque","year":"2022","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R4","doi-asserted-by":"publisher","first-page":"2200424","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200424","article-title":"Monkeypox outbreak predominantly affecting men who have sex with men, Madrid, Spain, 26 April to 16 June 2022","volume":"27(22)","author":"I\u00f1igo Mart\u00ednez","year":"2022","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries\u2014April\u2013June 2022.","author":"Thornhill","year":"2022","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R6","unstructured":"UK Health Security Agency. Investigation into monkeypox outbreak in England, technical brief #4. London, England: United Kingdom Health Security Agency; 2022. Accessed August 2, 2022. https:\/\/www.gov.uk\/government\/publications\/monkeypox-outbreak-technical-briefings"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R7","doi-asserted-by":"publisher","article-title":"Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective cohort study.","author":"Tar\u00edn-Vicente","DOI":"10.2139\/ssrn.4162718"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R8","doi-asserted-by":"publisher","first-page":"e072410","DOI":"10.1136\/bmj-2022-072410","article-title":"Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series.","volume":"378","author":"Patel","year":"2022","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R9","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7132e3","article-title":"Epidemiologic and clinical characteristics of monkeypox cases\u2014United States, May 17\u2013July 22, 2022","volume":"71","author":"Philpott","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R10","unstructured":"European Centers for Disease Prevention and Control; World Health Organization Regional Office for Europe. Joint ECDC-WHO Reginal Office for Europe monkeypox surveillance bulletin. Stockholm, Sweden: European Centers for Disease Prevention and Control; 2022. Accessed August 3, 2022. https:\/\/monkeypoxreport.ecdc.europa.eu."},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human monkeypox.","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R12","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1128\/AAC.00208-15","article-title":"Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.","volume":"59","author":"Berhanu","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R13","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK.","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral tecovirimat for the treatment of smallpox.","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R15","doi-asserted-by":"publisher","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","article-title":"Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022.","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R16","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1086\/378357","article-title":"Effectiveness of postexposure vaccination for the prevention of smallpox: results of a delphi analysis.","volume":"188","author":"Massoudi","year":"2003","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/oxfordjournals.aje.a121615","article-title":"The 1972 smallpox outbreak in Khulna Municipality, Bangladesh. II. Effectiveness of surveillance and containment in urban epidemic control.","volume":"99","author":"Sommer","year":"1974","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R18","unstructured":"Food and Drug Administration. JYNNEOS [package insert], revised: 06\/2021. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https:\/\/www.fda.gov\/media\/131078\/download"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R19","unstructured":"Food and Drug Administration. ACAM2000 [package insert], revised: 03\/2018. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2018. https:\/\/www.fda.gov\/media\/75792\/download"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R20","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1097\/QAD.0000000000003067","article-title":"Trends in HIV prevalence by self-report among MSM diagnosed and reported with gonorrhea in six United States jurisdictions from 2010 to 2019.","volume":"35","author":"Stenger","year":"2021","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R21","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/S1473-3099(19)30294-4","article-title":"Outbreak of human monkeypox in Nigeria in 2017\u201318: a clinical and epidemiological report.","volume":"19","author":"Yinka-Ogunleye","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R22","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1093\/cid\/ciaa143","article-title":"Clinical course and outcome of human monkeypox in Nigeria.","volume":"71","author":"Ogoina","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R23","unstructured":"World Health Organization. Multi-county monkeypox outbreak: situation update. Geneva, Switzerland: World Health Organization; 2022. Accessed July 18, 2022. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON390"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R24","doi-asserted-by":"publisher","DOI":"10.1177\/09564624221114998","article-title":"Human monkeypox coinfection with acute HIV: an exuberant presentation.","author":"de Sousa","year":"2022","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R25","doi-asserted-by":"publisher","first-page":"ofv040","DOI":"10.1093\/ofid\/ofv040","article-title":"Safety and immunogenicity of modified vaccinia Ankara-Bavarian Nordic smallpox vaccine in vaccinia-naive and experienced human immunodeficiency virus-infected individuals: an open-label, controlled clinical phase II trial","volume":"2(2)","author":"Overton","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/infdis\/jis753","article-title":"Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.","volume":"207","author":"Greenberg","year":"2013","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.mm7132e4-202208110811-R27","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1016\/j.vaccine.2020.01.058","article-title":"A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS.","volume":"38","author":"Overton","year":"2020","journal-title":"Vaccine"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T08:27:00Z","timestamp":1660206420000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7132e4.htm?s_cid=mm7132e4_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":27,"journal-issue":{"issue":"32","published-online":{"date-parts":[[2022,8,12]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7132e4","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,12]]},"published":{"date-parts":[[2022,8,12]]}}}